| Dr Reynalda M Deguzman, MD | |
|
4361 Boniface Pkwy, Anchorage, AK 99504-4316 | |
| (907) 333-1211 | |
| (907) 333-8660 |
| Full Name | Dr Reynalda M Deguzman |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 4361 Boniface Pkwy, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922218064 | NPI | - | NPPES |
| MD1732 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | AA1732 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Reynalda M Deguzman, MD 4361 Boniface Pkwy, Anchorage, AK 99504-4316 Ph: (907) 333-1211 | Dr Reynalda M Deguzman, MD 4361 Boniface Pkwy, Anchorage, AK 99504-4316 Ph: (907) 333-1211 |
News Archive
SNM is pleased that the U.S. Congress has passed a fix to freeze the conversion factor at the 2009 rate for physicians, which will ensure that millions of patients continue to receive medical coverage for critical diagnostic imaging tests and therapeutics.
SPO Medical Inc., a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced it has signed a Memorandum of Understanding (MOU) with MetroSleep Inc, a US corporation that specializes in products to diagnose and treat sleep apnea through at-home testing. The MOU enables the integration of SPO Medical' ASIC chip-set technology in a new MetroSleep product offering for the Sleep Disturbance Breathing monitoring market.
Glioblastoma (GBM), the brain cancer better known for having killed Senator Ted Kennedy a few months ago, is the most aggressive and lethal of all brain tumours.
Computer technology that provides parents with customized safety information can be an effective way to help their children avoid injury, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Children's Center.
Repros Therapeutics Inc. today announced that the Company is sending a reply to the FDA's Division of Metabolism and Endocrinology Products following the Company's receipt of FDA's comments on the proposed Phase II study of Androxal® (enclomiphene) in the treatment of Type II diabetes under Repros' open IND. On February 2, 2010 the Company announced that Repros received confirmation from the Agency that the new IND is effective.
› Verified 4 days ago
Stacey R Nieder, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3801 University Lake Dr Ste 301, Anchorage, AK 99508 Phone: 907-929-5888 Fax: 907-929-5882 | |
Mr. Thomas Gilman Lang, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 741 Sesame St, 1-b, Anchorage, AK 95503 Phone: 907-561-5801 Fax: 907-563-1372 | |
Jean Colesberry Persons, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1546 Coffey Lane, Anchorage, AK 99501 Phone: 907-277-4187 | |
Douglas C Smith, MD General Practice Medicare: Medicare Enrolled Practice Location: 2900 Providence Dr, Anchorage, AK 99508 Phone: 907-345-0728 Fax: 907-345-0728 | |
Dr. Jean Milner Eaton, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 8700 E Klatt Rd, Anchorage, AK 99507 Phone: 907-345-3606 | |
Dr. Arthur Dewey Tilgner, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5011 Spenard Rd, Anchorage, AK 99517 Phone: 907-245-4359 | |
Dr. Ronald E Christensen, MD General Practice Medicare: Medicare Enrolled Practice Location: 9500 Independence Dr, Ste 900, Anchorage, AK 99507 Phone: 907-522-1341 Fax: 907-522-1343 |